Atlas Trials

Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients

Clinical trial NCT04681768 · COMPLETED

Trial details

NCT number
NCT04681768
Sponsor
Technical University of Munich
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer/ Metastatic Breast Cancer
Start date
2020-12-22
Primary completion
2025-01-20
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.